NeuroDerm (NDRM) Misses Q4 EPS by 3c

NeuroDerm (NASDAQ: NDRM) reported Q4 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $-11100000000 , versus $0 reported last year.

For earnings history and earnings-related data on NeuroDerm (NDRM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c